Exact Mass: 215.1513
Exact Mass Matches: 215.1513
Found 99 metabolites which its exact mass value is equals to given mass value 215.1513,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ethyl butylacetylaminopropionate
CONFIDENCE standard compound; INTERNAL_ID 1192; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8182; ORIGINAL_PRECURSOR_SCAN_NO 8180 CONFIDENCE standard compound; INTERNAL_ID 1192; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8200; ORIGINAL_PRECURSOR_SCAN_NO 8198 CONFIDENCE standard compound; INTERNAL_ID 1192; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8129; ORIGINAL_PRECURSOR_SCAN_NO 8127 CONFIDENCE standard compound; INTERNAL_ID 1192; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8126; ORIGINAL_PRECURSOR_SCAN_NO 8124 CONFIDENCE standard compound; INTERNAL_ID 1192; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8142; ORIGINAL_PRECURSOR_SCAN_NO 8139 CONFIDENCE standard compound; INTERNAL_ID 1192; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8176; ORIGINAL_PRECURSOR_SCAN_NO 8173
Rimantadine Hydrochloride
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
N-Nonanoylglycine
N-Nonanoylglycine is an acylglycine with C-9 fatty acid group as the acyl moiety. Acylglycines 1 possess a common amidoacetic acid moiety and are normally minor metabolites of fatty acids. Elevated levels of certain acylglycines appear in the urine and blood of patients with various fatty acid oxidation disorders. They are normally produced through the action of glycine N-acyltransferase which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine ↔ CoA + N-acylglycine. N-Nonanoylglycine is an acylglycine with C-9 fatty acid group as the acyl moiety.
2-((4,5-Dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Hexaminolevulinate
V - Various > V04 - Diagnostic agents C1420 - Photosensitizing Agent
MLS000069661-01!1-(1-ADAMANTYL)ETHYLAMINE HYDROCHLORIDE
4-Morpholinepropanoicacid, 2,6-dimethyl-, ethyl ester
Pyrimido[1,2-a]benzimidazole, 2,3,4,10-tetrahydro-7,8,10-trimethyl- (9CI)
3,5-dimethyl-1-(2-methylbenzyl)-1H-pyrazol-4-amine(SALTDATA: FREE)
3,5-dimethyl-1-(4-methylbenzyl)-1H-pyrazol-4-amine(SALTDATA: FREE)
tert-Butyl 3-(2-hydroxyethyl)pyrrolidine-1-carboxylate
tert-butyl 5-hydroxy-2-methyl-piperidine-1-carboxylate
Carbamicacid,[(1S)-1-formyl-2,2-dimethylpropyl]-,1,1-dimethylethylester
4-[(2-isopropyl-1H-imidazol-1-yl)methyl]aniline(SALTDATA: FREE)
tert-butyl 3-(hydroxymethyl)-3-methylpyrrolidine-1-carboxylate
tert-Butyl 3-hydroxy-3-methyl-piperidine-1-carboxylate
Tramazoline
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
tert-butyl (3R,4R)-3-(hydroxymethyl)-4-methylpyrrolidine-1-carboxylate
2-TRIMETHYLSILYL-1-ETHYLBORONIC ACID DIETHANOLAMINE ESTER
5-METHYL-4-[(4-METHYL-1H-PYRAZOL-1-YL)METHYL]ISOXAZOLE-3-CARBOXYLIC ACID
tert-butyl (2R)-2-(2-hydroxyethyl)pyrrolidine-1-carboxylate
1-Pyrrolidinecarboxylicacid,3-ethoxy-,1,1-dimethylethylester(9CI)
1H-Azepine-1-carboxylicacid,2-ethoxyhexahydro-,ethylester(9CI)
tert-butyl 3-(3-hydroxypropyl)azetidine-1-carboxylate
tert-butyl 3-(2-hydroxypropan-2-yl)azetidine-1-carboxylate
tert-butyl 4-hydroxy-2-methylpiperidine-1-carboxylate
2-Methyl-2-propanyl (2R,4R)-4-hydroxy-2-methyl-1-piperidinecarboxylate
3,5-DIMETHYL-1-(3-METHYL-BENZYL)-1H-PYRAZOL-4-YLAMINE
1-piperidinecarboxylic acid, 4-hydroxy-3-methyl-, 1,1-dimethylethyl ester, (3r,4s)-rel-
(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate
tert-butyl 3-hydroxy-4-methylpiperidine-1-carboxylate
(3-HYDROXY-CYCLOHEXYL)-CARBAMIC ACID TERT-BUTYL ESTER
memantine hydrochloride
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents
(1r,3R,5S,7r)-3,5-dimethyladamantan-1-amine hydrochloride
Hexaminolevulinate
V - Various > V04 - Diagnostic agents C1420 - Photosensitizing Agent
